Navigation Links
Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting
Date:2/22/2013

BOCA RATON, Fla., Feb. 22, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists a non-invasive option for treating their patients who are diagnosed with skin cancer!

(Logo: http://photos.prnewswire.com/prnh/20130222/FL64841LOGO )

We cordially invite all AAD attendees to visit our booth (#2701) at the upcoming 71st Annual Academy of Dermatology Meeting in Miami Beach, FL and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™ non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "We are very excited by the feedback we are getting from our Dermatology customers. They are experiencing excellent outcomes as their patients are very happy with the results and they feel their investment in the SRT-100 was well worth it," declared Joe Sardano , President/CEO, Sensus Healthcare.    
See you in Miami!

About Sensus Healthcare:  
Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamus Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing the most accurate and safest treatment possible resulting in proven outcomes. Visit our web site to learn more about Sensus Healthcare…………..Taking new aim at treating skin cancer!  www.sensushealthcare.com 

Media Contact: 
Michelle Verina  
Public Relations  
561-922-5808 Ext. *100  
michelle@sensushealthcare.com  


'/>"/>
SOURCE Sensus Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... software solutions for pharmaceutical research and development (R&D), today announced the launch ... data analysis and interpretation for the rapidly evolving field of precision medicine. ...
(Date:1/19/2017)... ... January 18, 2017 , ... The ... (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, ... subject to the existing policy. AMIA recommended that NIH earmark funding for researchers ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
(Date:1/18/2017)... Jan. 18, 2017   Boston Biomedical , an ... to target cancer stemness pathways, will feature data from ... at the 2017 ASCO Gastrointestinal Cancers Symposium, held from ... Napabucasin is an orally-administered investigational agent ... i Cancer stem cells (CSCs) possess the property ...
Breaking Biology Technology:
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
(Date:12/20/2016)... Dec. 20, 2016 The rising popularity ... and leasing is stoking significant interest in keyless ... technology, Bluetooth low energy (BLE), biometrics and near-field ... next wave of wireless technologies in the automotive ... to advanced access systems opens the market to ...
Breaking Biology News(10 mins):